Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
4.770
+0.590 (14.11%)
Oct 23, 2025, 4:00 PM EDT - Market closed

Turn Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
2.521.552.34.21
Research & Development
0.230.250.01-
Operating Expenses
2.751.82.314.21
Operating Income
-2.75-1.8-2.31-4.21
Interest Expense
----0.09
Interest & Investment Income
0.020.030.020.01
Pretax Income
-2.56-1.77-2.29-4.29
Income Tax Expense
---0
Net Income
-2.56-1.77-2.29-4.29
Net Income to Common
-2.56-1.77-2.29-4.29
Shares Outstanding (Basic)
272726-
Shares Outstanding (Diluted)
272726-
Shares Change (YoY)
2.66%1.33%--
EPS (Basic)
-0.09-0.07-0.09-
EPS (Diluted)
-0.09-0.07-0.09-
EBITDA
-2.7-1.75-2.26-4.16
D&A For EBITDA
0.050.050.040.05
EBIT
-2.75-1.8-2.31-4.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q